The Latin America, Middle East and Africa Omics Lab Services Market should witness market growth of 16.8% CAGR during the forecast period (2022-2028).
The expansion of the diagnostic laboratory market is anticipated to be aided by rising demand for inexpensive services, increased awareness of customized medicine, and technological improvements. Another key factor projected to propel the market for omics lab services is the increase in government efforts to offer different amenities, such as reimbursement for diagnostic tests. As part of the integration of many clinical tests, including microbiological testing, several diagnostic labs are collaborating with healthcare organizations.
Genomic testing is often ongoing, similar to genetic treatment, and genomic technology has the potential to provide groundbreaking new medications. Genomic testing is becoming more and more important as the demand for precision treatment grows. The treatment of three babies with X-linked hypohidrotic ectodermal dysplasia recently provided experimental proof of this. In this study, the prenatal intervention was employed to effectively produce a recombinant version of the lacking protein.
Some of the key trends of the Transcriptomics Market are an expansion in the number of biopharmaceutical companies, academic institutions, and research institutes, as well as significant investments in biomarker development and cancer research. Given the vast regions covered by developed-world developments in molecular and omics-based technologies, their adoption and implementation in developed countries remain dubious. Aging and population expansion, as well as increased incidence of risk factors, have made cancer a pervasive problem in African countries.
The Brazil market dominated the LAMEA Omics Lab Services Market by Country in 2021; thereby, achieving a market value of $2.4 billion by 2028. The Argentina market is estimated to grow at a CAGR of 17.4% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 16.5% during (2022-2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
The expansion of the diagnostic laboratory market is anticipated to be aided by rising demand for inexpensive services, increased awareness of customized medicine, and technological improvements. Another key factor projected to propel the market for omics lab services is the increase in government efforts to offer different amenities, such as reimbursement for diagnostic tests. As part of the integration of many clinical tests, including microbiological testing, several diagnostic labs are collaborating with healthcare organizations.
Genomic testing is often ongoing, similar to genetic treatment, and genomic technology has the potential to provide groundbreaking new medications. Genomic testing is becoming more and more important as the demand for precision treatment grows. The treatment of three babies with X-linked hypohidrotic ectodermal dysplasia recently provided experimental proof of this. In this study, the prenatal intervention was employed to effectively produce a recombinant version of the lacking protein.
Some of the key trends of the Transcriptomics Market are an expansion in the number of biopharmaceutical companies, academic institutions, and research institutes, as well as significant investments in biomarker development and cancer research. Given the vast regions covered by developed-world developments in molecular and omics-based technologies, their adoption and implementation in developed countries remain dubious. Aging and population expansion, as well as increased incidence of risk factors, have made cancer a pervasive problem in African countries.
The Brazil market dominated the LAMEA Omics Lab Services Market by Country in 2021; thereby, achieving a market value of $2.4 billion by 2028. The Argentina market is estimated to grow at a CAGR of 17.4% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 16.5% during (2022-2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
Scope of the Study
By Business
- Diagnostic Labs
- Research Institutes
- Hospitals
By End-Use
- Cancer
- Pharmaco
- Population Studies & Genealogy
- Reproductive
- Skincare
- Nutrition, Vitamin & Supplements
- Forensics & Others
By Type
- Proteomics
- Transcriptomic
- Metabolomics
- Genomics
- Epigenetics
By Product
- Hardware Equipment
- Testing / Lab Services
- Analytics / Interpretation
By Frequency of Service
- Continuous
- Repeat
- One-off
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- BGI Group
- Q2 Solutions (IQVIA)
- Flomics Biotech
- PhenoSwitch Bioscience
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Omics Lab Services Market, by Business
1.4.2 LAMEA Omics Lab Services Market, by End-Use
1.4.3 LAMEA Omics Lab Services Market, by Type
1.4.4 LAMEA Omics Lab Services Market, by Product
1.4.5 LAMEA Omics Lab Services Market, by Frequency of Service
1.4.6 LAMEA Omics Lab Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Omics Lab Services Market
Chapter 4. LAMEA Omics Lab Services Market by Business
4.1 LAMEA Diagnostic Labs Market by Country
4.2 LAMEA Research Institutes Market by Country
4.3 LAMEA Hospitals Market by Country
Chapter 5. LAMEA Omics Lab Services Market by End-Use
5.1 LAMEA Cancer Market by Country
5.2 LAMEA Pharmaco Market by Country
5.3 LAMEA Population Studies & Genealogy Market by Country
5.4 LAMEA Reproductive Market by Country
5.5 LAMEA Skincare Market by Country
5.6 LAMEA Nutrition, Vitamin & Supplements Market by Country
5.7 LAMEA Forensics & Others Market by Country
Chapter 6. LAMEA Omics Lab Services Market by Type
6.1 LAMEA Proteomics Market by Country
6.2 LAMEA Transcriptomic Market by Country
6.3 LAMEA Metabolomics Market by Country
6.4 LAMEA Genomics Market by Country
6.5 LAMEA Epigenetics Market by Country
Chapter 7. LAMEA Omics Lab Services Market by Product
7.1 LAMEA Hardware Equipment Market by Country
7.2 LAMEA Testing / Lab Services Market by Country
7.3 LAMEA Analytics / Interpretation Market by Country
Chapter 8. LAMEA Omics Lab Services Market by Frequency of Service
8.1 LAMEA Continuous Market by Country
8.2 LAMEA Repeat Market by Country
8.3 LAMEA One-off Market by Country
Chapter 9. LAMEA Omics Lab Services Market by Country
9.1 Brazil Omics Lab Services Market
9.1.1 Brazil Omics Lab Services Market by Business
9.1.2 Brazil Omics Lab Services Market by End-Use
9.1.3 Brazil Omics Lab Services Market by Type
9.1.4 Brazil Omics Lab Services Market by Product
9.1.5 Brazil Omics Lab Services Market by Frequency of Service
9.2 Argentina Omics Lab Services Market
9.2.1 Argentina Omics Lab Services Market by Business
9.2.2 Argentina Omics Lab Services Market by End-Use
9.2.3 Argentina Omics Lab Services Market by Type
9.2.4 Argentina Omics Lab Services Market by Product
9.2.5 Argentina Omics Lab Services Market by Frequency of Service
9.3 UAE Omics Lab Services Market
9.3.1 UAE Omics Lab Services Market by Business
9.3.2 UAE Omics Lab Services Market by End-Use
9.3.3 UAE Omics Lab Services Market by Type
9.3.4 UAE Omics Lab Services Market by Product
9.3.5 UAE Omics Lab Services Market by Frequency of Service
9.4 Saudi Arabia Omics Lab Services Market
9.4.1 Saudi Arabia Omics Lab Services Market by Business
9.4.2 Saudi Arabia Omics Lab Services Market by End-Use
9.4.3 Saudi Arabia Omics Lab Services Market by Type
9.4.4 Saudi Arabia Omics Lab Services Market by Product
9.4.5 Saudi Arabia Omics Lab Services Market by Frequency of Service
9.5 South Africa Omics Lab Services Market
9.5.1 South Africa Omics Lab Services Market by Business
9.5.2 South Africa Omics Lab Services Market by End-Use
9.5.3 South Africa Omics Lab Services Market by Type
9.5.4 South Africa Omics Lab Services Market by Product
9.5.5 South Africa Omics Lab Services Market by Frequency of Service
9.6 Nigeria Omics Lab Services Market
9.6.1 Nigeria Omics Lab Services Market by Business
9.6.2 Nigeria Omics Lab Services Market by End-Use
9.6.3 Nigeria Omics Lab Services Market by Type
9.6.4 Nigeria Omics Lab Services Market by Product
9.6.5 Nigeria Omics Lab Services Market by Frequency of Service
9.7 Rest of LAMEA Omics Lab Services Market
9.7.1 Rest of LAMEA Omics Lab Services Market by Business
9.7.2 Rest of LAMEA Omics Lab Services Market by End-Use
9.7.3 Rest of LAMEA Omics Lab Services Market by Type
9.7.4 Rest of LAMEA Omics Lab Services Market by Product
9.7.5 Rest of LAMEA Omics Lab Services Market by Frequency of Service
Chapter 10. Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 Agilent Technologies, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.3 Qiagen N.V.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.4 Quest Diagnostics Incorporated
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Illumina, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 BGI Group
10.6.1 Company Overview
10.7 Q2 Solutions (IQVIA)
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.8 Flomics Biotech
10.8.1 Company Overview
10.9 PhenoSwitch Bioscience
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- BGI Group
- Q2 Solutions (IQVIA)
- Flomics Biotech
- PhenoSwitch Bioscience
Methodology
LOADING...
